Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 2 | 0 |
| May 2026 | 6 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 16, 2026 22:01 UTC |
Grogan William KChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 31,877 | $0.00 Strike: $64.25 | $0.00 |
DisclosureSEC source: 0001694002-26-000011 · wk-form4_1789596117.xml · derivative · entry 3 Grogan William K · CIK 0001694002 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,877 Underlying: Common Stock, par value $0.01 per share · 31,877 shares Expires 2036-09-14 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| September 14, 2026 Filed Sep 16, 2026 22:01 UTC |
Grogan William KChief Financial Officer
|
GrantCommon Stock, par value $0.01 per share | 12,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001694002-26-000011 · wk-form4_1789596117.xml · nonDerivative · entry 2 Grogan William K · CIK 0001694002 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,096 F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| September 14, 2026 Filed Sep 16, 2026 22:01 UTC |
Grogan William KChief Financial Officer
|
GrantCommon Stock, par value $0.01 per share | 62,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001694002-26-000011 · wk-form4_1789596117.xml · nonDerivative · entry 1 Grogan William K · CIK 0001694002 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,256 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on September 14, 2027, and 50% will vest on September 14, 2028. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:46 UTC |
Rackliffe PhilipCEO, AIS
|
Tax withholdingCommon Stock, par value $0.01 per share | 798 | $70.56 | $56,306.88 |
DisclosureSEC source: 0002027284-26-000013 · wk-form4_1788554780.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AIS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,533 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:45 UTC |
O'Neill Kevin MichaelCEO, PDx
|
Tax withholdingCommon Stock, par value $0.01 per share | 718 | $70.56 | $50,662.08 |
DisclosureSEC source: 0001951605-26-000008 · wk-form4_1788554702.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,026 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:44 UTC |
Newcomb George A.Chief Accounting Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 112 | $70.56 | $7,902.72 |
DisclosureSEC source: 0001952158-26-000008 · wk-form4_1788554645.xml · nonDerivative · entry 1 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,515 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:43 UTC |
Kass-Hout TahaChief Technology Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,502 | $70.56 | $105,981.12 |
DisclosureSEC source: 0001960652-26-000011 · wk-form4_1788554579.xml · nonDerivative · entry 1 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,467 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:42 UTC |
Jimenez Frank RGC & Corporate Secretary
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,480 | $70.56 | $104,428.80 |
DisclosureSEC source: 0001465175-26-000025 · wk-form4_1788554541.xml · nonDerivative · entry 1 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,321 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:41 UTC |
Holton Adam YChief People Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 673 | $70.56 | $47,486.88 |
DisclosureSEC source: 0001657919-26-000009 · wk-form4_1788554494.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,533 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:40 UTC |
Estrampes CatherineChief Commer. & Growth Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 508 | $70.56 | $35,844.48 |
DisclosureSEC source: 0002131383-26-000006 · wk-form4_1788554438.xml · nonDerivative · entry 1 Estrampes Catherine · CIK 0002131383 · Chief Commer. & Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,573 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:39 UTC |
Arduini Peter JDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.01 per share | 6,303 | $70.56 | $444,739.68 |
DisclosureSEC source: 0001323134-26-000022 · wk-form4_1788554361.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,606 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:18 UTC |
Kass-Hout TahaChief Technology Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,296 | $71.23 | $92,314.08 |
DisclosureSEC source: 0001960652-26-000009 · wk-form4_1788466702.xml · nonDerivative · entry 2 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,969 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:18 UTC |
Kass-Hout TahaChief Technology Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,644 | $71.23 | $117,102.12 |
DisclosureSEC source: 0001960652-26-000009 · wk-form4_1788466702.xml · nonDerivative · entry 1 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,265 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:18 UTC |
Rackliffe PhilipCEO, AIS
|
Tax withholdingCommon Stock, par value $0.01 per share | 340 | $71.23 | $24,218.20 |
DisclosureSEC source: 0002027284-26-000011 · wk-form4_1788466724.xml · nonDerivative · entry 3 Rackliffe Philip · CIK 0002027284 · CEO, AIS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,331 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:18 UTC |
Rackliffe PhilipCEO, AIS
|
Tax withholdingCommon Stock, par value $0.01 per share | 226 | $71.23 | $16,097.98 |
DisclosureSEC source: 0002027284-26-000011 · wk-form4_1788466724.xml · nonDerivative · entry 2 Rackliffe Philip · CIK 0002027284 · CEO, AIS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,671 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:18 UTC |
Rackliffe PhilipCEO, AIS
|
Tax withholdingCommon Stock, par value $0.01 per share | 290 | $71.23 | $20,656.70 |
DisclosureSEC source: 0002027284-26-000011 · wk-form4_1788466724.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AIS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,897 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:17 UTC |
Jimenez Frank RGC & Corporate Secretary
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,380 | $71.23 | $98,297.40 |
DisclosureSEC source: 0001465175-26-000023 · wk-form4_1788466662.xml · nonDerivative · entry 2 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,801 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:17 UTC |
Jimenez Frank RGC & Corporate Secretary
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,751 | $71.23 | $124,723.73 |
DisclosureSEC source: 0001465175-26-000023 · wk-form4_1788466662.xml · nonDerivative · entry 1 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,181 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:17 UTC |
Holton Adam YChief People Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 659 | $71.23 | $46,940.57 |
DisclosureSEC source: 0001657919-26-000007 · wk-form4_1788466636.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,206 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:16 UTC |
Bankes JeannetteCEO, Patient Care Solutions
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,064 | $71.23 | $75,788.72 |
DisclosureSEC source: 0001920839-26-000007 · wk-form4_1788466599.xml · nonDerivative · entry 1 Bankes Jeannette · CIK 0001920839 · CEO, Patient Care Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,293 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:16 UTC |
Arduini Peter JDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.01 per share | 5,472 | $71.23 | $389,770.56 |
DisclosureSEC source: 0001323134-26-000020 · wk-form4_1788466573.xml · nonDerivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,909 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:16 UTC |
Arduini Peter JDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.01 per share | 6,043 | $71.23 | $430,442.89 |
DisclosureSEC source: 0001323134-26-000020 · wk-form4_1788466573.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,381 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:14 UTC |
Holton Adam YChief People Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,360 | $73.69 | $100,218.40 |
DisclosureSEC source: 0001657919-26-000004 · wk-form4_1787084055.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,865 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 22, 2026 Filed May 26, 2026 22:44 UTC |
Lobo KevinDirector
|
PurchaseCommon Stock, par value $0.01 per share | 10,000 | $64.18 | $641,800.00 |
DisclosureSEC source: 0001519419-26-000011 · wk-form4_1779835492.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,363 Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:05 UTC |
Rackliffe PhilipCEO, AIS
|
GrantCommon Stock, par value $0.01 per share | 16,458 | $0.00 | $0.00 |
DisclosureSEC source: 0002027284-26-000008 · wk-form4_1779221108.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AIS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,187 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on May 15, 2028, and 50% will vest on May 15, 2029. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:04 UTC |
Bankes JeannetteCEO, Patient Care Solutions
|
Tax withholdingCommon Stock, par value $0.01 per share | 5,535 | $62.67 | $346,878.45 |
DisclosureSEC source: 0001920839-26-000004 · wk-form4_1779221065.xml · nonDerivative · entry 1 Bankes Jeannette · CIK 0001920839 · CEO, Patient Care Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,357 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 12, 2026 Filed May 13, 2026 20:19 UTC |
Hochman Rodney FDirector
|
PurchaseCommon Stock, par value $0.01 per share | 1,618 | $62.03 | $100,364.54 |
DisclosureSEC source: 0001468966-26-000004 · wk-form4_1778703550.xml · nonDerivative · entry 1 Hochman Rodney F · CIK 0001468966 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By family trust Disclosed balance after: 1,618 Read SEC document |
| May 08, 2026 Filed May 12, 2026 00:16 UTC |
Yang Watkin Phoebe L.Director
|
PurchaseCommon Stock, par value $0.01 per share | 1,000 | $63.01 | $63,006.30 |
DisclosureSEC source: 0001940538-26-000002 · wk-form4_1778544964.xml · nonDerivative · entry 2 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,702 F3 · price: The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:08 UTC |
Madden Anne TDirector
|
GrantCommon Stock, par value $0.01 per share | 2,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001684059-26-000002 · wk-form4_1778544519.xml · nonDerivative · entry 2 Madden Anne T · CIK 0001684059 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,479 F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:08 UTC |
Madden Anne TDirector
|
GrantCommon Stock, par value $0.01 per share | 3,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001684059-26-000002 · wk-form4_1778544519.xml · nonDerivative · entry 1 Madden Anne T · CIK 0001684059 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,197 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan"). F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:12 UTC |
Hochman Rodney FDirector
|
GrantCommon Stock, par value $0.01 per share | 2,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001468966-26-000002 · wk-form4_1778544776.xml · nonDerivative · entry 2 Hochman Rodney F · CIK 0001468966 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,886 F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:12 UTC |
Hochman Rodney FDirector
|
GrantCommon Stock, par value $0.01 per share | 3,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001468966-26-000002 · wk-form4_1778544776.xml · nonDerivative · entry 1 Hochman Rodney F · CIK 0001468966 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,197 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan"). F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:07 UTC |
Stromberg William JDirector
|
GrantCommon Stock, par value $0.01 per share | 3,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001352578-26-000006 · wk-form4_1778544462.xml · nonDerivative · entry 1 Stromberg William J · CIK 0001352578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,916 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:14 UTC |
CULP H LAWRENCE JRDirector
|
GrantCommon Stock, par value $0.01 per share | 4,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001205247-26-000008 · wk-form4_1778544891.xml · nonDerivative · entry 2 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,442 F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:14 UTC |
CULP H LAWRENCE JRDirector
|
GrantCommon Stock, par value $0.01 per share | 3,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001205247-26-000008 · wk-form4_1778544891.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,285 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan"). F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:12 UTC |
LESJAK CATHERINE ADirector
|
GrantCommon Stock, par value $0.01 per share | 3,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001256992-26-000004 · wk-form4_1778544729.xml · nonDerivative · entry 1 LESJAK CATHERINE A · CIK 0001256992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,702 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:10 UTC |
Lobo KevinDirector
|
GrantCommon Stock, par value $0.01 per share | 3,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001519419-26-000009 · wk-form4_1778544646.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,363 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:16 UTC |
Yang Watkin Phoebe L.Director
|
GrantCommon Stock, par value $0.01 per share | 3,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001940538-26-000002 · wk-form4_1778544964.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,702 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 06, 2026 Filed May 7, 2026 20:09 UTC |
Stromberg William JDirector
|
PurchaseCommon Stock, par value $0.01 per share | 1,000 | $61.69 | $61,689.20 |
DisclosureSEC source: 0001352578-26-000004 · wk-form4_1778184524.xml · nonDerivative · entry 1 Stromberg William J · CIK 0001352578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,330 Read SEC document |
| May 06, 2026 Filed May 7, 2026 20:14 UTC |
CULP H LAWRENCE JRDirector
|
PurchaseCommon Stock, par value $0.01 per share | 80,805 | $61.88 | $5,000,076.03 |
DisclosureSEC source: 0001205247-26-000006 · wk-form4_1778184869.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By holding company Disclosed balance after: 151,207 F1 · price: The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $61.50 to $62.22, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 01, 2026 Filed May 1, 2026 15:38 UTC |
SACCARO JAMESChief Financial Officer
|
PurchaseCommon Stock, par value $0.01 per share | 3,310 | $60.60 | $200,585.01 |
DisclosureSEC source: 0001593636-26-000008 · wk-form4_1777649933.xml · nonDerivative · entry 1 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,471 F1 · price: The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $60.59 to $60.60, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 30, 2026 Filed Apr 30, 2026 20:21 UTC |
Jimenez Frank RGC & Corporate Secretary
|
PurchaseCommon Stock, par value $0.01 per share | 1,750 | $60.45 | $105,787.50 |
DisclosureSEC source: 0001465175-26-000015 · wk-form4_1777580461.xml · nonDerivative · entry 1 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,932 Read SEC document |
| April 30, 2026 Filed Apr 30, 2026 20:20 UTC |
Arduini Peter JDirector · President and CEO
|
PurchaseCommon Stock, par value $0.01 per share | 4,169 | $59.93 | $249,827.33 |
DisclosureSEC source: 0001323134-26-000014 · wk-form4_1777580401.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,424 Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:08 UTC |
Lobo KevinDirector
|
GrantCommon Stock, par value $0.01 per share | 777 | $0.00 | $0.00 |
DisclosureSEC source: 0001519419-26-000006 · wk-form4_1773778094.xml · nonDerivative · entry 1 Lobo Kevin · CIK 0001519419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 777 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) March 13, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:24 UTC |
Rackliffe PhilipCEO, AVS
|
GrantEmployee Stock Option (right to buy) · Derivative | 24,598 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0002027284-26-000006 · wk-form4_1772659448.xml · derivative · entry 2 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,598 Underlying: Common Stock, par value $0.01 per share · 24,598 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:24 UTC |
Rackliffe PhilipCEO, AVS
|
GrantCommon Stock, par value $0.01 per share | 9,356 | $0.00 | $0.00 |
DisclosureSEC source: 0002027284-26-000006 · wk-form4_1772659448.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,729 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:27 UTC |
Bankes JeannetteCEO, Patient Care Solutions
|
GrantEmployee Stock Option (right to buy) · Derivative | 18,038 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001920839-26-000002 · wk-form4_1772659635.xml · derivative · entry 2 Bankes Jeannette · CIK 0001920839 · CEO, Patient Care Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,038 Underlying: Common Stock, par value $0.01 per share · 18,038 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:27 UTC |
Bankes JeannetteCEO, Patient Care Solutions
|
GrantCommon Stock, par value $0.01 per share | 6,861 | $0.00 | $0.00 |
DisclosureSEC source: 0001920839-26-000002 · wk-form4_1772659635.xml · nonDerivative · entry 1 Bankes Jeannette · CIK 0001920839 · CEO, Patient Care Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,892 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:26 UTC |
Jimenez Frank RGC & Corporate Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 28,697 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001465175-26-000008 · wk-form4_1772659615.xml · derivative · entry 2 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,697 Underlying: Common Stock, par value $0.01 per share · 28,697 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:26 UTC |
Jimenez Frank RGC & Corporate Secretary
|
GrantCommon Stock, par value $0.01 per share | 10,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001465175-26-000008 · wk-form4_1772659615.xml · nonDerivative · entry 1 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,182 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.